CORRELATION BETWEEN COVID-19 SEVERITY AND NONINVASIVE ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)

被引：0
|
作者：
Tungtrongchitr, Nuttapat
Srivanitchapoom, Nantaporn
Hirunpat, Pornrujee
Sungkanuparph, Somnuek
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
MAFLD; COVID-19; fibrosis; 8; score; 4; non-alcoholic fatty liver disease fibrosis score;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1509
引用
收藏
页码：S1394 / S1395
页数：2
相关论文
共 50 条
  • [31] Identification of Hepatic Dendritic Cells in Liver Biopsies in Patients with Metabolic Dysfunction-Associated Fatty Liver Diseas (MAFLD) and Obesity
    Barranco-Fragoso, Beatriz
    Pal, Shreya C.
    Diaz-Orozco, Luis E.
    Dorantes-Heredia, Rita
    Qi, Xingshun
    Mendez-Sanchez, Nahum
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [32] Altitude and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in China: A Population-Based Study
    Wang, Yufei
    Meng, Qiong
    Zhang, Jin
    Guo, Bing
    Li, Nanyan
    Deng, Qian
    Hu, Julinling
    Deji, Quzong
    Guan, Han
    Danzhen, Wangjiu
    Yu, Hui
    Li, Zhifeng
    Zhou, Junmin
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2024,
  • [33] Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
    Subramanian, Pallavi
    Hampe, Jochen
    Tacke, Frank
    Chavakis, Triantafyllos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [34] A screening study of high-risk groups for liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Chao, Guanqun
    Zhu, Yue
    Bao, Yang
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [35] Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
    Lopes Vasques-Monteiro, Isabela Macedo
    Souza-Mello, Vanessa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (16) : 1738 - 1750
  • [36] Metabolic dysfunction-associated fatty liver disease in people living with HIV
    Michel, Maurice
    Labenz, Christian
    Armandi, Angelo
    Kaps, Leonard
    Kremer, Wolfgang Maximilian
    Galle, Peter R.
    Grimm, Daniel
    Sprinzl, Martin
    Schattenberg, Joern M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [37] The relationship of circulating MOTS-c level with liver fibrosis and metabolic components in patients with metabolic dysfunction-associated fatty liver disease
    Kirik, A.
    Dogru, T.
    Yanik, B.
    Sen, H.
    Eroglu, M.
    Baykan, O.
    Bozyel, E. A.
    Ergene, A.
    Selcuk, E.
    Tasci, I.
    Sonmez, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (17) : 8074 - 8080
  • [38] Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment
    Yu, Qiang
    He, Ruixin
    Jiang, Haowen
    Wu, Ji
    Xi, Zhifeng
    He, Kang
    Liu, Yongbo
    Zhou, Tao
    Feng, Mingxuan
    Wan, Ping
    Yan, Hexin
    Xia, Qiang
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (06) : 1034 - 1041
  • [39] From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
    Flisiak-Jackiewicz, Marta
    Bobrus-Chociej, Anna
    Wasilewska, Natalia
    Lebensztejn, Dariusz Marek
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 11
  • [40] Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD)
    Zhao, Ying
    Zhou, Yanni
    Wang, Dan
    Huang, Ziwei
    Xiao, Xiong
    Zheng, Qing
    Li, Shengfu
    Long, Dan
    Feng, Li
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
12345